ImmunoGen, Inc. (NASDAQ:IMGN) Q2 2023 Earnings Call Transcri

Operator: Good morning and welcome to ImmunoGen’s second quarter 2023 financial and operating results conference call. Today’s conference is being recorded.

Related Keywords

Istanbul , Turkey , Japan , Germany , China , Asthika Goonewardene , Kelly Shi , Isabel Kalafonos , Joe Catanzaro , Jonathan Chang , Anna Berkenblit , Swayampakula Ramakanth , John Newman , William Blair , Etzer Darout , Andy Hsieh , Renee Lentini , Piper Sandler , Mark Enyedy , Michael Vasconcelles , Kathleen Moore , Anabel Chan , Peter Lawson , Isabel Kalofonos , Philipp Harter , Michael Schmidt , Nasdaq , Immunogen Inc , Jp Morgan , Barclays , Call Transcript July , Chief Commercial Officer , Chief Medical Officer , Medical Affairs , Risk Factors , Gyn Onc Journal , Boris Peaker , Whati Ll , Elahere Compendium ,